PMC:7289100 / 30167-30523
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T381 | 148-166 | Disease | denotes | rheumatic diseases | http://purl.obolibrary.org/obo/MONDO_0005554 |
T382 | 335-348 | Disease | denotes | viral disease | http://purl.obolibrary.org/obo/MONDO_0005108 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T238 | 203-208 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T192 | 0-356 | Sentence | denotes | Since the breakout of the Covid-19 in late 2019 in China, many unresolved issues regarding both dealing with the fate of the preexisting autoimmune rheumatic diseases in patients who are affected by the virus including those under immunosuppressive and biologic therapy, as well as the impact of these therapies on the severity of the viral disease itself. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T424 | 26-34 | SP_7 | denotes | Covid-19 |
T425 | 137-147 | UBERON:0002405 | denotes | autoimmune |
T426 | 203-208 | NCBITaxon:10239 | denotes | virus |
T427 | 231-248 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T428 | 335-340 | NCBITaxon:10239 | denotes | viral |
T70814 | 26-34 | SP_7 | denotes | Covid-19 |
T14206 | 137-147 | UBERON:0002405 | denotes | autoimmune |
T1510 | 203-208 | NCBITaxon:10239 | denotes | virus |
T87559 | 231-248 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T60635 | 335-340 | NCBITaxon:10239 | denotes | viral |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1010 | 170-178 | Species | denotes | patients | Tax:9606 |
1012 | 26-34 | Disease | denotes | Covid-19 | MESH:C000657245 |
1013 | 148-166 | Disease | denotes | rheumatic diseases | MESH:D012216 |
1014 | 335-348 | Disease | denotes | viral disease | MESH:D001102 |